It is also interesting to note that in a recent report, Nucci et al. [23] described a glaucoma patient with medically controlled IOP who experienced disease progression concomitantly with the onset of mild cognitive impairment and positivity for CSF markers of AD (decreased Aβ and elevated levels of total and phosphorylated tau). Here, MAPT is linked to glaucoma.